First-trimester biomarkers and the risk of cerebral palsy

Mads Langager Larsen1, Gija Rackauskaite2, Kasper Pihl3

  • 1Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Obstetrics and Gynaecology, Copenhagen University Hospital - Amager-Hvidovre, Hvidovre, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Insights

First-trimester biomarkers like beta-hCG and PAPP-A show weak associations with cerebral palsy (CP). These common biomarkers have inadequate predictive abilities for early CP detection.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Neurology
  • Developmental Pediatrics

Background:

  • Cerebral palsy (CP) is the leading cause of severe motor disability in children, stemming from early brain damage.
  • Identifying early indicators for CP is crucial for timely intervention and improved outcomes.

Purpose of the Study:

  • To investigate the association between first-trimester biomarker levels and the subsequent development of cerebral palsy (CP).
  • To assess the clinical utility of these biomarkers in developing an early prediction model for CP.

Main Methods:

  • A nationwide cohort study analyzed data from 258,057 singleton live births with first-trimester assessments.
  • Biomarkers including beta-hCG, PAPP-A, nuchal translucency, and biparietal diameter (BPD) were measured in multiples of the median (MoM).
  • Logistic regression was employed to construct an early prediction model for CP.

Main Results:

  • Lower mean beta-hCG levels were significantly associated with CP (0.96 MoM vs. 1.04 MoM, p=0.01).
  • Mean PAPP-A levels showed a trend towards lower values in CP cases (0.96 MoM vs. 1.01 MoM, p=0.07).
  • A higher likelihood of CP was observed in fetuses with BPD measurements below the fifth percentile (7.5% vs. 5%, p=0.045). The developed prediction model demonstrated poor discrimination.

Conclusions:

  • First-trimester pregnancies diagnosed with CP exhibited lower beta-hCG and PAPP-A values, though associations varied.
  • The predictive capability of common first-trimester biomarkers for CP is limited, rendering them inadequate for early prediction models.
Abstract